Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
Overview
Authors
Affiliations
Adrenocortical carcinoma (ACC) is a rare but aggressive malignant cancer that has been attracting growing attention over recent decades. This study aims to integrate protein interaction networks with gene expression profiles to identify potential biomarkers with prognostic value . Three microarray data sets were downloaded from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs) according to the normalization annotation information. Enrichment analyses were utilized to describe biological functions. A protein-protein interaction network (PPI) of the DEGs was developed, and the modules were analyzed using STRING and Cytoscape. LASSO Cox regression was used to identify independent prognostic factors. The Kaplan-Meier method for the integrated expression score was applied to analyze survival outcomes. A receiver operating characteristic (ROC) curve was constructed with area under curve (AUC) analysis to determine the diagnostic ability of the candidate biomarkers. A total of 150 DEGs and 24 significant hub genes with functional enrichment were identified as candidate prognostic biomarkers. LASSO Cox regression suggested that , , , and were independent prognostic factors in ACC. In multivariate Cox analysis, the integrated expression scores of the modules showed statistical significance in predicting . Meanwhile, ROC curves were generated to validate the ability of the Cox model to predict prognosis. The AUC index for the integrated genes scores was 0.861 ( < 0.0001). In conclusion, the present study identifies DEGs and hub genes that may be involved in poor prognosis and early recurrence of ACC. The expression levels of , , , and are of high prognostic value, and may help us understand better the underlying carcinogenesis or progression of ACC. Further studies are required to elucidate molecular pathogenesis and alteration in signaling pathways for these genes in ACC.
Cheng H, Meng X, Zhang Y, Wang P, Lu Y Sci Rep. 2025; 15(1):2679.
PMID: 39838029 PMC: 11751337. DOI: 10.1038/s41598-025-86338-8.
Molecular and Genetics Perspectives on Primary Adrenocortical Hyperfunction Disorders.
Kim S, Chaudhary P, Kim S Int J Mol Sci. 2024; 25(21).
PMID: 39518893 PMC: 11545009. DOI: 10.3390/ijms252111341.
[Clinical treatment and prognosis of adrenocortical carcinoma with venous tumor thrombus].
Liu S, Liu L, Liu Z, Zhang F, Ma L, Tian X Beijing Da Xue Xue Bao Yi Xue Ban. 2024; 56(4):624-630.
PMID: 39041556 PMC: 11284474.
Zhang C, Shen Q, Gao M, Li J, Pang B Heliyon. 2024; 10(4):e26061.
PMID: 38380029 PMC: 10877342. DOI: 10.1016/j.heliyon.2024.e26061.
Gao C, Fan X, Liu Y, Han Y, Liu S, Li H Int J Gen Med. 2023; 16:5817-5839.
PMID: 38106976 PMC: 10723185. DOI: 10.2147/IJGM.S438479.